George Ng - Aug 8, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer
Signature
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 8, 2023
Transactions value $
$0
Form type
4
Date filed
8/9/2023, 04:51 PM
Next filing
Sep 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +400K $0.00 400K Aug 8, 2023 Common Stock 400K $0.00 Direct F1
transaction PCSA Restricted Stock Units Award $0 +400K +100% $0.00 800K Aug 8, 2023 Common Stock 400K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of one-third on 08/08/24, 08/08/25, and 08/08/26 or upon a change in control event.
F2 The restricted stock units vest upon the achievement of certain performance goals.